{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P10646",
      "entity_text" : "TFPI",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01498",
      "entity_text" : "emicizumab",
      "entity_type" : "protein"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "In this study, we investigated whether emicizumab interferes with the action of AT on FIXa and FXa or with the action of TFPI on FXa by means of enzymatic assays, and whether emicizumab impedes the anticoagulation activities of AT and TFPI through plasma thrombin generation assays.",
  "reading_complete" : "2020-08-02T11:54:10Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T11:52:35Z",
  "trigger" : "impedes",
  "evidence" : [ "emicizumab impedes the anticoagulation activities of AT and TFPI" ],
  "pmc_id" : "6524866",
  "score" : 0
}